Plaque Psoriasis Research Study (56 Weeks)

Adults aged 18 years or older with chronic plaque psoriasis for at least 6 months, may qualify to participate. Eligible participants must have plaque psoriasis covering 10% or more of their body, with moderate to severe disease at the time of study entry.

Participants will receive study medication (secukinumab) or placebo via injection under the skin on a weekly basis to start and then every 4 weeks, during each treatment period. Study medication and study-related care will be provided at no cost.  Reimbursement for study-related expenses may be provided.

Study participation will last up to 56 weeks and include about 15 visits to the study centre plus 6 home administrations.

Call the study centre near you, or register now.

Learn more about
Psoriasis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more